These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38148081)
1. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients. Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081 [TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling. Ishihara Y; Ohata Y; Takeyari S; Kitaoka T; Fujiwara M; Nakano Y; Yamamoto K; Yamada C; Yamamoto K; Michigami T; Mabe H; Yamaguchi T; Matsui K; Tamada I; Namba N; Yamamoto A; Etoh J; Kawaguchi A; Kosugi R; Ozono K; Kubota T Bone; 2021 Dec; 153():116135. PubMed ID: 34333162 [TBL] [Abstract][Full Text] [Related]
3. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. Ichikawa S; Austin AM; Gray AK; Econs MJ J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791 [TBL] [Abstract][Full Text] [Related]
4. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study). Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300 [TBL] [Abstract][Full Text] [Related]
5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631 [TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Zhang C; Zhao Z; Sun Y; Xu L; JiaJue R; Cui L; Pang Q; Jiang Y; Li M; Wang O; He X; He S; Nie M; Xing X; Meng X; Zhou X; Yan L; Kaplan JM; Insogna KL; Xia W Bone; 2019 Apr; 121():212-220. PubMed ID: 30682568 [TBL] [Abstract][Full Text] [Related]
7. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program. Rush ET; Johnson B; Aradhya S; Beltran D; Bristow SL; Eisenbeis S; Guerra NE; Krolczyk S; Miller N; Morales A; Ramesan P; Sarafrazi S; Truty R; Dahir K J Bone Miner Res; 2022 Feb; 37(2):202-214. PubMed ID: 34633109 [TBL] [Abstract][Full Text] [Related]
8. Familial hypophosphatemic rickets caused by a large deletion in PHEX gene. Saito T; Nishii Y; Yasuda T; Ito N; Suzuki H; Igarashi T; Fukumoto S; Fujita T Eur J Endocrinol; 2009 Oct; 161(4):647-51. PubMed ID: 19581284 [TBL] [Abstract][Full Text] [Related]
9. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets. Baroncelli GI; Grandone A; Aversa A; Sessa MR; Pelosini C; Michelucci A; Toschi B; Manca M; Isola A; Comberiati P Eur J Med Genet; 2024 Aug; 70():104958. PubMed ID: 38950880 [TBL] [Abstract][Full Text] [Related]
11. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment. Kinoshita Y; Fukumoto S Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780 [TBL] [Abstract][Full Text] [Related]
12. A novel c.2179T>C mutation blocked the intracellular transport of PHEX protein and caused X-linked hypophosphatemic rickets in a Chinese family. Li B; Wang X; Hao X; Liu Y; Wang Y; Shan C; Ao X; Liu Y; Bao H; Li P Mol Genet Genomic Med; 2020 Aug; 8(8):e1262. PubMed ID: 32511895 [TBL] [Abstract][Full Text] [Related]
13. X-linked hypophosphatemia caused by a deep intronic variant in PHEX identified by PCR-based RNA analysis of urine-derived cells. Grimbly C; Ludwig K; Wu Z; Caluseriu O; Rosolowsky E; Alexander RT; Ward LM; Rauch F Bone; 2023 Nov; 176():116839. PubMed ID: 37454963 [TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets. Lin X; Zhu Y; Luo J; Huang J J Pediatr Endocrinol Metab; 2018 Jul; 31(7):789-797. PubMed ID: 29858904 [TBL] [Abstract][Full Text] [Related]
15. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets. Li SS; Gu JM; Yu WJ; He JW; Fu WZ; Zhang ZL Int J Mol Med; 2016 Dec; 38(6):1703-1714. PubMed ID: 27840894 [TBL] [Abstract][Full Text] [Related]
16. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH. Igaki JM; Yamada M; Yamazaki Y; Koto S; Izawa M; Ariyasu D; Suzuki E; Hasegawa H; Hasegawa Y Endocr J; 2011; 58(8):647-55. PubMed ID: 21597229 [TBL] [Abstract][Full Text] [Related]
17. Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia. Ichikawa S; Gray AK; Bikorimana E; Econs MJ Calcif Tissue Int; 2013 Aug; 93(2):155-62. PubMed ID: 23700148 [TBL] [Abstract][Full Text] [Related]
18. A Novel Synonymous Variant of PHEX in a Patient with X-Linked Hypophosphatemia. Ma X; Pang Q; Zhang Q; Jiang Y; Wang O; Li M; Xing X; Xia W Calcif Tissue Int; 2022 Dec; 111(6):634-640. PubMed ID: 35831717 [TBL] [Abstract][Full Text] [Related]
19. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets. Xia W; Meng X; Jiang Y; Li M; Xing X; Pang L; Wang O; Pei Y; Yu LY; Sun Y; Hu Y; Zhou X Calcif Tissue Int; 2007 Dec; 81(6):415-20. PubMed ID: 18046499 [TBL] [Abstract][Full Text] [Related]
20. Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3'-UTR change as a possible cause. Sawatsubashi S; Takashi Y; Endo I; Kondo T; Abe M; Matsumoto T; Fukumoto S Bone; 2024 May; 182():117057. PubMed ID: 38412893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]